In an important study, a diabetic mouse transplanted with ESCs-derived insulin-secreting cells lowered the glucose level, however, resulted in teratoma formation, which limits its clinical potential in addressing diabetes and related complication [127]. This evidence concerns the gene INS and diabetes mellitus.